Related references
Note: Only part of the references are listed.Loss and revival of androgen receptor signaling in advanced prostate cancer
Nicolo Formaggio et al.
ONCOGENE (2021)
Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line
Katharina Klose et al.
PLOS ONE (2021)
PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
Sachiko Kitamura et al.
CANCER SCIENCE (2021)
Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α
Nives Skorja Milic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
Caroline E. Nunes-Xavier et al.
PROSTATE (2021)
Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism
Sugarniya Subramaniam et al.
CANCERS (2021)
Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine
James Meehan et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia
Longzhen Cui et al.
CANCER GENE THERAPY (2020)
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer
Monika Oberhuber et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Pyruvate Kinase M2 Promotes Prostate Cancer Metastasis Through Regulating ERK1/2-COX-2 Signaling
Wenjing Guo et al.
FRONTIERS IN ONCOLOGY (2020)
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
Takuma Uo et al.
FRONTIERS IN ONCOLOGY (2020)
The Implications of PDK1-4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
Emine Atas et al.
FRONTIERS IN ONCOLOGY (2020)
The role of protein tyrosine phosphatases in prostate cancer biology
Caroline E. Nunes-Xavier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Karine Flem-Karlsen et al.
SCIENTIFIC REPORTS (2019)
Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
Benjamin L. Woolbright et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
Tiziana Tataranni et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma
Caroline E. Nunes-Xavier et al.
DIAGNOSTIC PATHOLOGY (2019)
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
Janire Mingo et al.
NPJ PRECISION ONCOLOGY (2019)
The Metabolic Landscape of Prostate Cancer
Francesca Giunchi et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities
Giorgia Zadra et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer
Swatishree Sradhanjali et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
NMR-based metabolomics studies of human prostate cancer tissue
Ana Rita Lima et al.
METABOLOMICS (2018)
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
Jingjing Chen et al.
NATURE GENETICS (2018)
Advancing therapies in metastatic castration-resistant prostate cancer
Giulia Baciarello et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
Yangbo Feng et al.
CANCER MEDICINE (2018)
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets
Senthilmurugan Ramalingam et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers
Yali Zhong et al.
ONCOTARGET (2017)
Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel
Hong Sun et al.
ONCOTARGET (2017)
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
Rachel S. Kelly et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer
Jong-Lyel Roh et al.
CANCER LETTERS (2016)
Metabolic Alterations in Renal and Prostate Cancer
Chiara Ciccarese et al.
CURRENT DRUG METABOLISM (2016)
Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase
Adam Kinnaird et al.
EUROPEAN UROLOGY (2016)
The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro
Tatjana Harting et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Translational and clinical implications of the genetic landscape of prostate cancer
Daniel E. Spratt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
Yaqing Li et al.
ONCOTARGET (2016)
The genomic evolution of human prostate cancer
T. Mitchell et al.
BRITISH JOURNAL OF CANCER (2015)
Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate
Rosa Ferriero et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies
E. David Crawford et al.
JOURNAL OF UROLOGY (2015)
Introduction to the molecular basis of cancer metabolism and the Warburg effect
Darleen C. Ngo et al.
MOLECULAR BIOLOGY REPORTS (2015)
Dichloroacetate and cancer: New home for an orphan drug?
Shyam Kankotia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation
Gopinath Sutendra et al.
CELL (2014)
NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells
Mithun Kailavasan et al.
NMR IN BIOMEDICINE (2014)
The Mutational Landscape of Prostate Cancer
Christopher E. Barbieri et al.
EUROPEAN UROLOGY (2013)
The Genomic Landscape of Prostate Cancer
Lien Spans et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Molecular Pathogenesis and Progression of Prostate Cancer
Randy Schrecengost et al.
SEMINARS IN ONCOLOGY (2013)
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Tanupriya Contractor et al.
CANCER RESEARCH (2012)
The androgen/androgen receptor axis in prostate cancer
Eric G. Bluemn et al.
CURRENT OPINION IN ONCOLOGY (2012)
The genomic landscape of prostate cancer
Sylvan C. Baca et al.
Frontiers in Endocrinology (2012)
The CAPRA-S Score A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy
Matthew R. Cooperberg et al.
CANCER (2011)
Metabolic alterations and targeted therapies in prostate cancer
Richard Flavin et al.
JOURNAL OF PATHOLOGY (2011)
Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation
Wengang Cao et al.
PROSTATE (2008)
Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues
J Torres et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
